nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A7—Docetaxel—head and neck cancer	0.139	0.294	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.139	0.294	CbGbCtD
Fluticasone Propionate—CYP3A5—Docetaxel—head and neck cancer	0.104	0.221	CbGbCtD
Fluticasone Propionate—CYP3A4—Vinblastine—head and neck cancer	0.0493	0.104	CbGbCtD
Fluticasone Propionate—CYP3A4—Docetaxel—head and neck cancer	0.0406	0.0861	CbGbCtD
Fluticasone Propionate—Nasal irritation—Fluorouracil—head and neck cancer	0.0213	0.0546	CcSEcCtD
Fluticasone Propionate—Skin atrophy—Hydroxyurea—head and neck cancer	0.017	0.0436	CcSEcCtD
Fluticasone Propionate—Telangiectasia—Fluorouracil—head and neck cancer	0.0157	0.0402	CcSEcCtD
Fluticasone Propionate—Nasal discomfort—Fluorouracil—head and neck cancer	0.0129	0.0331	CcSEcCtD
Fluticasone Propionate—Scab—Fluorouracil—head and neck cancer	0.0116	0.0298	CcSEcCtD
Fluticasone Propionate—Cutaneous hypersensitivity—Docetaxel—head and neck cancer	0.0109	0.028	CcSEcCtD
Fluticasone Propionate—Allergic contact dermatitis—Fluorouracil—head and neck cancer	0.0106	0.0271	CcSEcCtD
Fluticasone Propionate—Skin irritation—Fluorouracil—head and neck cancer	0.00855	0.0219	CcSEcCtD
Fluticasone Propionate—Lower respiratory tract infection—Docetaxel—head and neck cancer	0.00781	0.02	CcSEcCtD
Fluticasone Propionate—Blister—Hydroxyurea—head and neck cancer	0.00713	0.0183	CcSEcCtD
Fluticasone Propionate—Lacrimation—Fluorouracil—head and neck cancer	0.00629	0.0161	CcSEcCtD
Fluticasone Propionate—Blister—Fluorouracil—head and neck cancer	0.00513	0.0131	CcSEcCtD
Fluticasone Propionate—Stinging—Fluorouracil—head and neck cancer	0.00457	0.0117	CcSEcCtD
Fluticasone Propionate—Lacrimation—Docetaxel—head and neck cancer	0.00454	0.0116	CcSEcCtD
Fluticasone Propionate—Eye irritation—Fluorouracil—head and neck cancer	0.00433	0.0111	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Docetaxel—head and neck cancer	0.0042	0.0108	CcSEcCtD
Fluticasone Propionate—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.00407	0.0104	CcSEcCtD
Fluticasone Propionate—Lacrimation increased—Fluorouracil—head and neck cancer	0.00401	0.0103	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Fluorouracil—head and neck cancer	0.00401	0.0103	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.0039	0.00999	CcSEcCtD
Fluticasone Propionate—Throat sore—Docetaxel—head and neck cancer	0.0037	0.00948	CcSEcCtD
Fluticasone Propionate—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00367	0.0094	CcSEcCtD
Fluticasone Propionate—Dermatitis contact—Fluorouracil—head and neck cancer	0.00366	0.00936	CcSEcCtD
Fluticasone Propionate—Dermatitis atopic—Docetaxel—head and neck cancer	0.00361	0.00923	CcSEcCtD
Fluticasone Propionate—Face oedema—Hydroxyurea—head and neck cancer	0.0036	0.00922	CcSEcCtD
Fluticasone Propionate—Rash erythematous—Docetaxel—head and neck cancer	0.00349	0.00892	CcSEcCtD
Fluticasone Propionate—Ageusia—Docetaxel—head and neck cancer	0.0033	0.00844	CcSEcCtD
Fluticasone Propionate—Rhinorrhoea—Docetaxel—head and neck cancer	0.0033	0.00844	CcSEcCtD
Fluticasone Propionate—Eye irritation—Docetaxel—head and neck cancer	0.00313	0.008	CcSEcCtD
Fluticasone Propionate—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00294	0.00752	CcSEcCtD
Fluticasone Propionate—Lacrimation increased—Docetaxel—head and neck cancer	0.0029	0.00742	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Hydroxyurea—head and neck cancer	0.00287	0.00736	CcSEcCtD
Fluticasone Propionate—Infestation—Hydroxyurea—head and neck cancer	0.00287	0.00736	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Vinblastine—head and neck cancer	0.00282	0.00721	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00281	0.00719	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Vinblastine—head and neck cancer	0.00281	0.00719	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Docetaxel—head and neck cancer	0.00259	0.00664	CcSEcCtD
Fluticasone Propionate—Irritability—Fluorouracil—head and neck cancer	0.00256	0.00656	CcSEcCtD
Fluticasone Propionate—Candida infection—Docetaxel—head and neck cancer	0.00255	0.00652	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Fluorouracil—head and neck cancer	0.0024	0.00615	CcSEcCtD
Fluticasone Propionate—Lightheadedness—Docetaxel—head and neck cancer	0.00239	0.00611	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Vinblastine—head and neck cancer	0.00229	0.00585	CcSEcCtD
Fluticasone Propionate—Erythema—Hydroxyurea—head and neck cancer	0.00225	0.00575	CcSEcCtD
Fluticasone Propionate—Malaise—Vinblastine—head and neck cancer	0.00222	0.00569	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00216	0.00552	CcSEcCtD
Fluticasone Propionate—Hypertension—Vinblastine—head and neck cancer	0.00213	0.00544	CcSEcCtD
Fluticasone Propionate—Clobetasol propionate—CYP1A1—head and neck cancer	0.00211	0.4	CrCbGaD
Fluticasone Propionate—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00208	0.00534	CcSEcCtD
Fluticasone Propionate—Pneumonia—Fluorouracil—head and neck cancer	0.00208	0.00533	CcSEcCtD
Fluticasone Propionate—Discomfort—Vinblastine—head and neck cancer	0.00207	0.0053	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Fluorouracil—head and neck cancer	0.00207	0.0053	CcSEcCtD
Fluticasone Propionate—Infestation—Fluorouracil—head and neck cancer	0.00207	0.0053	CcSEcCtD
Fluticasone Propionate—Atrial fibrillation—Docetaxel—head and neck cancer	0.00204	0.00524	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Docetaxel—head and neck cancer	0.00203	0.00519	CcSEcCtD
Fluticasone Propionate—Malaise—Hydroxyurea—head and neck cancer	0.00203	0.00519	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Fluorouracil—head and neck cancer	0.00201	0.00515	CcSEcCtD
Fluticasone Propionate—Epistaxis—Fluorouracil—head and neck cancer	0.00195	0.005	CcSEcCtD
Fluticasone Propionate—Sinusitis—Fluorouracil—head and neck cancer	0.00194	0.00497	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.0019	0.00486	CcSEcCtD
Fluticasone Propionate—Discomfort—Hydroxyurea—head and neck cancer	0.00189	0.00484	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00185	0.00473	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Fluorouracil—head and neck cancer	0.00184	0.00472	CcSEcCtD
Fluticasone Propionate—Oedema—Hydroxyurea—head and neck cancer	0.00183	0.00469	CcSEcCtD
Fluticasone Propionate—Infection—Hydroxyurea—head and neck cancer	0.00182	0.00466	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Hydroxyurea—head and neck cancer	0.0018	0.0046	CcSEcCtD
Fluticasone Propionate—Skin disorder—Hydroxyurea—head and neck cancer	0.00178	0.00456	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Docetaxel—head and neck cancer	0.00174	0.00447	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Docetaxel—head and neck cancer	0.00173	0.00444	CcSEcCtD
Fluticasone Propionate—Pain—Vinblastine—head and neck cancer	0.00172	0.0044	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Fluorouracil—head and neck cancer	0.00166	0.00425	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Vinblastine—head and neck cancer	0.00166	0.00424	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Docetaxel—head and neck cancer	0.00165	0.00422	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00164	0.00421	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Hydroxyurea—head and neck cancer	0.00163	0.00418	CcSEcCtD
Fluticasone Propionate—Erythema—Fluorouracil—head and neck cancer	0.00162	0.00414	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Vinblastine—head and neck cancer	0.00159	0.00407	CcSEcCtD
Fluticasone Propionate—Pain—Hydroxyurea—head and neck cancer	0.00157	0.00401	CcSEcCtD
Fluticasone Propionate—Vision blurred—Fluorouracil—head and neck cancer	0.00152	0.0039	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00151	0.00387	CcSEcCtD
Fluticasone Propionate—Pneumonia—Docetaxel—head and neck cancer	0.0015	0.00385	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.0015	0.0114	CbGpPWpGaD
Fluticasone Propionate—PGR—Cellular roles of Anthrax toxin—MAPK1—head and neck cancer	0.0015	0.0113	CbGpPWpGaD
Fluticasone Propionate—Infestation NOS—Docetaxel—head and neck cancer	0.00149	0.00382	CcSEcCtD
Fluticasone Propionate—Infestation—Docetaxel—head and neck cancer	0.00149	0.00382	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Vinblastine—head and neck cancer	0.00148	0.00379	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Docetaxel—head and neck cancer	0.00145	0.00372	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Hydroxyurea—head and neck cancer	0.00145	0.00371	CcSEcCtD
Fluticasone Propionate—Epistaxis—Docetaxel—head and neck cancer	0.00141	0.00361	CcSEcCtD
Fluticasone Propionate—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00139	0.0105	CbGpPWpGaD
Fluticasone Propionate—Chest pain—Fluorouracil—head and neck cancer	0.00138	0.00352	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Vinblastine—head and neck cancer	0.00138	0.00352	CcSEcCtD
Fluticasone Propionate—Discomfort—Fluorouracil—head and neck cancer	0.00136	0.00348	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00135	0.00346	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.00134	0.0102	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—YAP1—head and neck cancer	0.00134	0.0102	CbGpPWpGaD
Fluticasone Propionate—Hypoaesthesia—Docetaxel—head and neck cancer	0.00133	0.00341	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Docetaxel—head and neck cancer	0.00133	0.00341	CcSEcCtD
Fluticasone Propionate—Dizziness—Vinblastine—head and neck cancer	0.00133	0.0034	CcSEcCtD
Fluticasone Propionate—Oedema—Fluorouracil—head and neck cancer	0.00132	0.00338	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00132	0.00338	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Docetaxel—head and neck cancer	0.00132	0.00337	CcSEcCtD
Fluticasone Propionate—Infection—Fluorouracil—head and neck cancer	0.00131	0.00336	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Fluorouracil—head and neck cancer	0.00129	0.00331	CcSEcCtD
Fluticasone Propionate—Tachycardia—Fluorouracil—head and neck cancer	0.00129	0.0033	CcSEcCtD
Fluticasone Propionate—Vomiting—Vinblastine—head and neck cancer	0.00128	0.00327	CcSEcCtD
Fluticasone Propionate—Headache—Vinblastine—head and neck cancer	0.00126	0.00322	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Hydroxyurea—head and neck cancer	0.00125	0.00321	CcSEcCtD
Fluticasone Propionate—Eye disorder—Docetaxel—head and neck cancer	0.00125	0.00321	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Docetaxel—head and neck cancer	0.00124	0.00319	CcSEcCtD
Fluticasone Propionate—NR3C1—Adipogenesis—CEBPA—head and neck cancer	0.00124	0.00941	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Hydroxyurea—head and neck cancer	0.00121	0.0031	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Docetaxel—head and neck cancer	0.00121	0.0031	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Docetaxel—head and neck cancer	0.00121	0.00309	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0012	0.00308	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Docetaxel—head and neck cancer	0.0012	0.00307	CcSEcCtD
Fluticasone Propionate—Nausea—Vinblastine—head and neck cancer	0.00119	0.00306	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—head and neck cancer	0.00119	0.009	CbGpPWpGaD
Fluticasone Propionate—Dyspnoea—Fluorouracil—head and neck cancer	0.00118	0.00301	CcSEcCtD
Fluticasone Propionate—Mental disorder—Docetaxel—head and neck cancer	0.00117	0.00301	CcSEcCtD
Fluticasone Propionate—Malnutrition—Docetaxel—head and neck cancer	0.00117	0.00299	CcSEcCtD
Fluticasone Propionate—Erythema—Docetaxel—head and neck cancer	0.00117	0.00299	CcSEcCtD
Fluticasone Propionate—Vomiting—Hydroxyurea—head and neck cancer	0.00117	0.00298	CcSEcCtD
Fluticasone Propionate—Rash—Hydroxyurea—head and neck cancer	0.00116	0.00296	CcSEcCtD
Fluticasone Propionate—Dermatitis—Hydroxyurea—head and neck cancer	0.00115	0.00296	CcSEcCtD
Fluticasone Propionate—Headache—Hydroxyurea—head and neck cancer	0.00115	0.00294	CcSEcCtD
Fluticasone Propionate—Pain—Fluorouracil—head and neck cancer	0.00113	0.00289	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Docetaxel—head and neck cancer	0.00112	0.00287	CcSEcCtD
Fluticasone Propionate—Nausea—Hydroxyurea—head and neck cancer	0.00109	0.00279	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Fluorouracil—head and neck cancer	0.00109	0.00278	CcSEcCtD
Fluticasone Propionate—Urticaria—Fluorouracil—head and neck cancer	0.00105	0.00268	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Fluorouracil—head and neck cancer	0.00104	0.00267	CcSEcCtD
Fluticasone Propionate—Triamcinolone—PTGS2—head and neck cancer	0.00104	0.196	CrCbGaD
Fluticasone Propionate—Palpitations—Docetaxel—head and neck cancer	0.00103	0.00264	CcSEcCtD
Fluticasone Propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—head and neck cancer	0.00102	0.00774	CbGpPWpGaD
Fluticasone Propionate—Cough—Docetaxel—head and neck cancer	0.00102	0.00261	CcSEcCtD
Fluticasone Propionate—Hypertension—Docetaxel—head and neck cancer	0.00101	0.00258	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.001	0.00761	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—RARB—head and neck cancer	0.001	0.00759	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—STAT6—head and neck cancer	0.000994	0.00753	CbGpPWpGaD
Fluticasone Propionate—Chest pain—Docetaxel—head and neck cancer	0.000994	0.00254	CcSEcCtD
Fluticasone Propionate—Arthralgia—Docetaxel—head and neck cancer	0.000994	0.00254	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000987	0.00253	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Fluorouracil—head and neck cancer	0.000972	0.00249	CcSEcCtD
Fluticasone Propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—head and neck cancer	0.000972	0.00736	CbGpPWpGaD
Fluticasone Propionate—Dry mouth—Docetaxel—head and neck cancer	0.000972	0.00249	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Ca-dependent events—MAPK1—head and neck cancer	0.000953	0.00722	CbGpPWpGaD
Fluticasone Propionate—Anaphylactic shock—Docetaxel—head and neck cancer	0.000952	0.00244	CcSEcCtD
Fluticasone Propionate—Oedema—Docetaxel—head and neck cancer	0.000952	0.00244	CcSEcCtD
Fluticasone Propionate—Infection—Docetaxel—head and neck cancer	0.000946	0.00242	CcSEcCtD
Fluticasone Propionate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000935	0.00709	CbGpPWpGaD
Fluticasone Propionate—Nervous system disorder—Docetaxel—head and neck cancer	0.000934	0.00239	CcSEcCtD
Fluticasone Propionate—Pruritus—Fluorouracil—head and neck cancer	0.000934	0.00239	CcSEcCtD
Fluticasone Propionate—Tachycardia—Docetaxel—head and neck cancer	0.00093	0.00238	CcSEcCtD
Fluticasone Propionate—Skin disorder—Docetaxel—head and neck cancer	0.000925	0.00237	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000914	0.00692	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—YAP1—head and neck cancer	0.000912	0.00691	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000905	0.00685	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Fluorouracil—head and neck cancer	0.000903	0.00231	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000893	0.00677	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000893	0.00676	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—CASP8—head and neck cancer	0.000877	0.00665	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000875	0.00663	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Fluorouracil—head and neck cancer	0.000873	0.00223	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000868	0.00222	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—STAT3—head and neck cancer	0.00085	0.00644	CbGpPWpGaD
Fluticasone Propionate—Dyspnoea—Docetaxel—head and neck cancer	0.000849	0.00217	CcSEcCtD
Fluticasone Propionate—Betamethasone—PTGS2—head and neck cancer	0.000848	0.161	CrCbGaD
Fluticasone Propionate—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00084	0.00636	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Fluorouracil—head and neck cancer	0.000839	0.00215	CcSEcCtD
Fluticasone Propionate—CYP3A7—Biological oxidations—NAT2—head and neck cancer	0.000832	0.0063	CbGpPWpGaD
Fluticasone Propionate—Rash—Fluorouracil—head and neck cancer	0.000832	0.00213	CcSEcCtD
Fluticasone Propionate—Dermatitis—Fluorouracil—head and neck cancer	0.000831	0.00213	CcSEcCtD
Fluticasone Propionate—Headache—Fluorouracil—head and neck cancer	0.000827	0.00212	CcSEcCtD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—NAT2—head and neck cancer	0.000821	0.00622	CbGpPWpGaD
Fluticasone Propionate—Pain—Docetaxel—head and neck cancer	0.000814	0.00209	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—MAPK3—head and neck cancer	0.000812	0.00615	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.000811	0.00614	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000797	0.00603	CbGpPWpGaD
Fluticasone Propionate—Dexamethasone—CYP1A1—head and neck cancer	0.000789	0.15	CrCbGaD
Fluticasone Propionate—Feeling abnormal—Docetaxel—head and neck cancer	0.000785	0.00201	CcSEcCtD
Fluticasone Propionate—Nausea—Fluorouracil—head and neck cancer	0.000784	0.00201	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000779	0.00199	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—MAPK1—head and neck cancer	0.000773	0.00585	CbGpPWpGaD
Fluticasone Propionate—Abdominal pain—Docetaxel—head and neck cancer	0.000753	0.00193	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Docetaxel—head and neck cancer	0.000753	0.00193	CcSEcCtD
Fluticasone Propionate—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000733	0.00555	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000732	0.00555	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.000707	0.00536	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000704	0.00533	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Docetaxel—head and neck cancer	0.000702	0.0018	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PLC beta mediated events—MAPK1—head and neck cancer	0.000701	0.00531	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—head and neck cancer	0.000692	0.00524	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—G-protein mediated events—MAPK1—head and neck cancer	0.000689	0.00522	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Docetaxel—head and neck cancer	0.000674	0.00173	CcSEcCtD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—NOTCH1—head and neck cancer	0.000666	0.00504	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000654	0.00495	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Docetaxel—head and neck cancer	0.000652	0.00167	CcSEcCtD
Fluticasone Propionate—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000645	0.00489	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Docetaxel—head and neck cancer	0.00063	0.00161	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—HRAS—head and neck cancer	0.00062	0.0047	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—RARB—head and neck cancer	0.000611	0.00462	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Docetaxel—head and neck cancer	0.000606	0.00155	CcSEcCtD
Fluticasone Propionate—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000601	0.00456	CbGpPWpGaD
Fluticasone Propionate—Rash—Docetaxel—head and neck cancer	0.000601	0.00154	CcSEcCtD
Fluticasone Propionate—Dermatitis—Docetaxel—head and neck cancer	0.0006	0.00154	CcSEcCtD
Fluticasone Propionate—Headache—Docetaxel—head and neck cancer	0.000597	0.00153	CcSEcCtD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000593	0.00449	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK3—head and neck cancer	0.000568	0.0043	CbGpPWpGaD
Fluticasone Propionate—Nausea—Docetaxel—head and neck cancer	0.000566	0.00145	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—STAT3—head and neck cancer	0.000558	0.00423	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—YAP1—head and neck cancer	0.000556	0.00421	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—MAPK3—head and neck cancer	0.000553	0.00419	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000549	0.00416	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK1—head and neck cancer	0.00054	0.00409	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—MAPK3—head and neck cancer	0.000533	0.00404	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00053	0.00402	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—MAPK1—head and neck cancer	0.000526	0.00399	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—MAPK1—head and neck cancer	0.000507	0.00384	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—EGFR—head and neck cancer	0.000507	0.00384	CbGpPWpGaD
Fluticasone Propionate—Dexamethasone—PTGS2—head and neck cancer	0.000493	0.0935	CrCbGaD
Fluticasone Propionate—PLA2G4A—Metabolism—UROD—head and neck cancer	0.000492	0.00372	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—RARB—head and neck cancer	0.000483	0.00366	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PIK3CA—head and neck cancer	0.000469	0.00355	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.000448	0.00339	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—YAP1—head and neck cancer	0.000439	0.00333	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000436	0.0033	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—head and neck cancer	0.000434	0.00328	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Opioid Signalling—MAPK1—head and neck cancer	0.000431	0.00326	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—HRAS—head and neck cancer	0.000423	0.0032	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000421	0.00319	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000411	0.00311	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	0.000411	0.00311	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000405	0.00307	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.000394	0.00299	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—PTEN—head and neck cancer	0.000392	0.00297	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	0.00039	0.00295	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000384	0.00291	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—head and neck cancer	0.000383	0.0029	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000381	0.00289	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000376	0.00285	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000375	0.00284	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—PTEN—head and neck cancer	0.000374	0.00283	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—AKT1—head and neck cancer	0.000373	0.00283	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—AKT1—head and neck cancer	0.00036	0.00272	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.000353	0.00267	CbGpPWpGaD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000352	0.00266	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Phospholipid metabolism—PTEN—head and neck cancer	0.000346	0.00262	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—UROD—head and neck cancer	0.000343	0.0026	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KISS1—head and neck cancer	0.00034	0.00257	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—MAPK3—head and neck cancer	0.000335	0.00254	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—STAT3—head and neck cancer	0.000335	0.00254	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000322	0.00244	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000321	0.00243	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—MAPK3—head and neck cancer	0.00032	0.00242	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—MAPK1—head and neck cancer	0.000319	0.00241	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—EGFR—head and neck cancer	0.000318	0.00241	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000317	0.0024	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000306	0.00232	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—MAPK1—head and neck cancer	0.000304	0.0023	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000304	0.0023	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.000302	0.00228	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.0003	0.00227	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000297	0.00225	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—RARB—head and neck cancer	0.000294	0.00223	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000293	0.00222	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.000287	0.00218	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000282	0.00213	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—GRP—head and neck cancer	0.00028	0.00212	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.00028	0.00212	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000278	0.0021	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000276	0.00209	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000276	0.00209	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000276	0.00209	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—YAP1—head and neck cancer	0.000267	0.00203	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000267	0.00202	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—head and neck cancer	0.000264	0.002	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—HRAS—head and neck cancer	0.000256	0.00194	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.000253	0.00192	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000252	0.00191	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.00025	0.0019	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—UROD—head and neck cancer	0.000248	0.00188	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000246	0.00187	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KISS1—head and neck cancer	0.000246	0.00186	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—HRAS—head and neck cancer	0.000244	0.00185	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Phospholipid metabolism—PIK3CA—head and neck cancer	0.000244	0.00185	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000241	0.00182	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—STAT3—head and neck cancer	0.00023	0.00174	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000228	0.00173	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—AKT1—head and neck cancer	0.000226	0.00171	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000217	0.00164	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000217	0.00164	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000217	0.00164	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000216	0.00164	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000215	0.00163	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000214	0.00162	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.000214	0.00162	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NAT2—head and neck cancer	0.000204	0.00155	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000203	0.00154	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GRP—head and neck cancer	0.000202	0.00153	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KISS1—head and neck cancer	0.000201	0.00152	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.0002	0.00152	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—NOTCH1—head and neck cancer	0.000198	0.0015	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT6—head and neck cancer	0.000196	0.00149	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000193	0.00146	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000188	0.00142	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000182	0.00138	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—DPYD—head and neck cancer	0.000179	0.00136	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—YAP1—head and neck cancer	0.000174	0.00132	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—RARB—head and neck cancer	0.00017	0.00129	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—YAP1—head and neck cancer	0.00017	0.00129	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.000167	0.00127	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GRP—head and neck cancer	0.000165	0.00125	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT6—head and neck cancer	0.000161	0.00122	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—YAP1—head and neck cancer	0.000155	0.00117	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000154	0.00116	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000145	0.0011	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NAT2—head and neck cancer	0.000142	0.00108	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—YAP1—head and neck cancer	0.000142	0.00108	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000138	0.00105	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	0.000137	0.00104	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000136	0.00103	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000131	0.000992	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IL2—head and neck cancer	0.00013	0.000984	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000129	0.000978	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000128	0.000967	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—DPYD—head and neck cancer	0.000125	0.000945	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NOTCH1—head and neck cancer	0.000121	0.000913	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—YAP1—head and neck cancer	0.000118	0.000897	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—UROD—head and neck cancer	0.000115	0.000872	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000111	0.000843	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—head and neck cancer	0.00011	0.000837	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MAPK3—head and neck cancer	0.00011	0.000829	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—MAPK3—head and neck cancer	0.000104	0.000791	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NAT2—head and neck cancer	0.000103	0.000779	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—TYMS—head and neck cancer	0.000102	0.000773	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTM1—head and neck cancer	0.000101	0.000764	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—MAPK1—head and neck cancer	9.94e-05	0.000753	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GPX1—head and neck cancer	9.66e-05	0.000731	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP1A1—head and neck cancer	9.56e-05	0.000724	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—DPYD—head and neck cancer	9.02e-05	0.000683	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CA—head and neck cancer	8.63e-05	0.000653	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—YAP1—head and neck cancer	8.56e-05	0.000648	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—head and neck cancer	8.35e-05	0.000632	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—HRAS—head and neck cancer	7.98e-05	0.000605	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.85e-05	0.000595	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH1—head and neck cancer	7.84e-05	0.000594	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2—head and neck cancer	7.46e-05	0.000565	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—head and neck cancer	7.39e-05	0.000559	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TYMS—head and neck cancer	7.11e-05	0.000538	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—head and neck cancer	7.05e-05	0.000534	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTM1—head and neck cancer	7.03e-05	0.000532	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH1—head and neck cancer	6.97e-05	0.000528	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GPX1—head and neck cancer	6.73e-05	0.00051	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MAPK3—head and neck cancer	6.67e-05	0.000505	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1A1—head and neck cancer	6.66e-05	0.000505	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH1—head and neck cancer	6.4e-05	0.000485	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAPK3—head and neck cancer	6e-05	0.000454	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAPK1—head and neck cancer	5.71e-05	0.000432	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—head and neck cancer	5.7e-05	0.000432	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—head and neck cancer	5.69e-05	0.000431	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2—head and neck cancer	5.39e-05	0.000409	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—head and neck cancer	5.26e-05	0.000398	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TYMS—head and neck cancer	5.14e-05	0.000389	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTM1—head and neck cancer	5.08e-05	0.000385	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTEN—head and neck cancer	5.07e-05	0.000384	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTEN—head and neck cancer	4.96e-05	0.000376	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—head and neck cancer	4.95e-05	0.000375	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GPX1—head and neck cancer	4.86e-05	0.000368	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1A1—head and neck cancer	4.82e-05	0.000365	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NAT2—head and neck cancer	4.78e-05	0.000362	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—head and neck cancer	4.58e-05	0.000347	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HRAS—head and neck cancer	4.58e-05	0.000347	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—head and neck cancer	4.54e-05	0.000344	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—head and neck cancer	4.5e-05	0.000341	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2—head and neck cancer	4.41e-05	0.000334	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK3—head and neck cancer	4.34e-05	0.000328	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—head and neck cancer	4.3e-05	0.000325	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—DPYD—head and neck cancer	4.19e-05	0.000318	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTEN—head and neck cancer	4.15e-05	0.000314	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK1—head and neck cancer	4.13e-05	0.000312	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—head and neck cancer	4.13e-05	0.000312	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—head and neck cancer	4.04e-05	0.000306	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—YAP1—head and neck cancer	3.98e-05	0.000301	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—head and neck cancer	3.96e-05	0.0003	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MAPK3—head and neck cancer	3.85e-05	0.000292	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—head and neck cancer	3.74e-05	0.000284	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—head and neck cancer	3.71e-05	0.000281	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—head and neck cancer	3.58e-05	0.000271	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK3—head and neck cancer	3.54e-05	0.000268	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—head and neck cancer	3.5e-05	0.000265	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—head and neck cancer	3.46e-05	0.000262	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTEN—head and neck cancer	3.46e-05	0.000262	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK1—head and neck cancer	3.37e-05	0.000255	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—head and neck cancer	3.37e-05	0.000255	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HRAS—head and neck cancer	3.31e-05	0.000251	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—head and neck cancer	2.92e-05	0.000222	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—head and neck cancer	2.92e-05	0.000222	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—head and neck cancer	2.86e-05	0.000217	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—head and neck cancer	2.86e-05	0.000216	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—head and neck cancer	2.83e-05	0.000214	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HRAS—head and neck cancer	2.71e-05	0.000205	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—head and neck cancer	2.6e-05	0.000197	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTEN—head and neck cancer	2.5e-05	0.000189	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—head and neck cancer	2.44e-05	0.000185	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TYMS—head and neck cancer	2.39e-05	0.000181	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—head and neck cancer	2.39e-05	0.000181	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.36e-05	0.000179	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPX1—head and neck cancer	2.26e-05	0.000171	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.24e-05	0.00017	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—head and neck cancer	1.99e-05	0.000151	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.76e-05	0.000133	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—head and neck cancer	1.44e-05	0.000109	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.33e-05	0.000101	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTEN—head and neck cancer	1.16e-05	8.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—head and neck cancer	8.19e-06	6.2e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—head and neck cancer	6.69e-06	5.07e-05	CbGpPWpGaD
